176 related articles for article (PubMed ID: 16258272)
21. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
22. Potential causes and pathogenesis in autosomal dominant polycystic kidney disease.
Milutinovic J; Agodoa LY
Nephron; 1983; 33(2):139-44. PubMed ID: 6835461
[TBL] [Abstract][Full Text] [Related]
23. Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease.
Wilson PD
Am J Kidney Dis; 1991 Jun; 17(6):634-7. PubMed ID: 2042637
[TBL] [Abstract][Full Text] [Related]
24. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
[TBL] [Abstract][Full Text] [Related]
26. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
28. TRAF3 delays cyst formation induced by NF-κB signaling.
Sun L; Hu C; Zhang X
IUBMB Life; 2017 Mar; 69(3):170-178. PubMed ID: 28185403
[TBL] [Abstract][Full Text] [Related]
29. VEGF receptor inhibition slows the progression of polycystic kidney disease.
Tao Y; Kim J; Yin Y; Zafar I; Falk S; He Z; Faubel S; Schrier RW; Edelstein CL
Kidney Int; 2007 Dec; 72(11):1358-66. PubMed ID: 17882148
[TBL] [Abstract][Full Text] [Related]
30. [Structure and function of the experimental polycystic kidney induced by diphenylthiazole with special reference to renal micropuncture study].
Kubota K
Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):859-69. PubMed ID: 1484405
[TBL] [Abstract][Full Text] [Related]
31. Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease.
Radadiya PS; Thornton MM; Puri RV; Yerrathota S; Dinh-Phan J; Magenheimer B; Subramaniam D; Tran PV; Zhu H; Bolisetty S; Calvet JP; Wallace DP; Sharma M
JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33784251
[TBL] [Abstract][Full Text] [Related]
32. The
Kofotolios I; Bonios MJ; Adamopoulos M; Mourouzis I; Filippatos G; Boletis JN; Marinaki S; Mavroidis M
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397964
[TBL] [Abstract][Full Text] [Related]
33. In vitro modulation of tubular cyst regression in murine polycystic kidney disease.
Avner ED; Sweeney WE; Ellis D
Kidney Int; 1989 Dec; 36(6):960-8. PubMed ID: 2557482
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells.
Zheleznova NN; Wilson PD; Staruschenko A
Biochim Biophys Acta; 2011 Oct; 1812(10):1301-13. PubMed ID: 20959142
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis in polycystic kidney disease: involvement of caspases.
Ali SM; Wong VY; Kikly K; Fredrickson TA; Keller PM; DeWolf WE; Lee D; Brooks DP
Am J Physiol Regul Integr Comp Physiol; 2000 Mar; 278(3):R763-9. PubMed ID: 10712299
[TBL] [Abstract][Full Text] [Related]
36. Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease.
Galarreta CI; Grantham JJ; Forbes MS; Maser RL; Wallace DP; Chevalier RL
Am J Pathol; 2014 Jul; 184(7):1957-66. PubMed ID: 24815352
[TBL] [Abstract][Full Text] [Related]
37. Proliferative activity of cyst epithelium in human renal cystic diseases.
Nadasdy T; Laszik Z; Lajoie G; Blick KE; Wheeler DE; Silva FG
J Am Soc Nephrol; 1995 Jan; 5(7):1462-8. PubMed ID: 7703384
[TBL] [Abstract][Full Text] [Related]
38. Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD.
Nadella R; Blumer JB; Jia G; Kwon M; Akbulut T; Qian F; Sedlic F; Wakatsuki T; Sweeney WE; Wilson PD; Lanier SM; Park F
J Am Soc Nephrol; 2010 Aug; 21(8):1275-80. PubMed ID: 20488951
[TBL] [Abstract][Full Text] [Related]
39. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.
Torres VE; Sweeney WE; Wang X; Qian Q; Harris PC; Frost P; Avner ED
Kidney Int; 2003 Nov; 64(5):1573-9. PubMed ID: 14531789
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
